Immunopharmacology

Microbial/host interactions in health and disease: Who controls the cytokine network?
pp. 1-21(21)
Authors: Henderson B.; Poole S.; Wilson M.

On the structure of the amino-terminal domain ED1 of the B2 receptor
pp. 23-26(4)
Authors: Alla S.A.; Quitterer U.; Schroder C.; Blaukat A.; Horstmeyer A.; Dedio J.; Reilander H.; Muller-Esterl W.

[³H]1,3-di(2-tolyl) guanidine binds to a ₂ receptor on Jurkat cell membranes, but compounds fail to influence immunomodulatory events in human peripheral blood lymphocytes
pp. 27-39(13)
Authors: DeHaven-Hudkins D.L.; Daubert J.D.; Sawutz D.G.; Tiberio L.; Baine Y.

In vitro and in vivo biological activities of a novel nonpolyglutamable anti-folate, MX-68
pp. 41-46(6)
Authors: Mihara M.; Urakawa K.; Takagi N.; Moriya Y.; Takeda Y.

Nicotine inhibits the in vitro production of interleukin 2 and tumour necrosis factor- by human mononuclear cells
pp. 47-51(5)
Authors: Madretsma G.S.; Donze G.J.; van Dijk A.P.M.; Tak C.J.A.M.; Wilson J.H.P.; Zijlstra F.J.

In vivo and in vitro pharmacologic activity of the purine nucleoside phosphorylase inhibitor BCX-34: the role of GTP and dGTP
pp. 53-63(11)
Authors: Bantia S.; Montgomery J.A.; Johnson H.G.; Walsh G.M.

Treatment with 15-deoxyspergualin induces temporal suppression of hemopoiesis and changes thymocyte populations in mice
pp. 65-70(6)
Authors: Mochida-Nishimura K.; Tokunaga T.

Selective mitomycin C and cyclophosphamide induction of apoptosis in differentiating B lymphocytes compared to T lymphocytes in vivo
pp. 71-82(12)
Authors: Hemendinger R.A.; Bloom S.E.